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Objective: Prior studies have documented racial and ethnic disparities in rates of amputations for peripheral arterial disease
(PAD) in the United States. We analyze whether there are underlying differences in the types of treatment provided to
patients who are acutely hospitalized for PAD.
Methods: The 1998-2006 Nationwide Inpatient Sample was used to examine patterns of treatment. We considered a
hospitalization an acute admission for PAD if (1) the primary diagnosis was PAD, and (2) the patient was admitted
urgently or emergently or through an emergency department. Vascular interventions were designated as open bypass,
endovascular intervention, or major amputation, defined as disarticulation at the ankle or higher amputation.
Results: From 1998 through 2006, the likelihood of an endovascular procedure being performed during an acute
hospitalization for PAD increased from 11.5% to 35.3%, and open vascular procedures decreased from 34.9% to 25.4%.
The likelihood of a major amputation during an acute hospitalization for PAD decreased from 29.7% to 20.3%. Black and
Hispanic patients weremore likely than white patients to undergo amputation andwere less likely to have an endovascular
or open revascularization.
Conclusion: Use of endovascular procedures has increased and use of open vascular bypass has decreased in the inpatient
treatment of acute PAD. Although the overall likelihood of amputation has decreased, racial and ethnic differences persist,
with black and Hispanic patients experiencing a higher likelihood of amputation. (J Vasc Surg 2010;51:21S-26S.)Peripheral arterial disease (PAD) poses a significant
clinical and economic burden to individuals living in the
United States. When left untreated, PAD can lead to sig-
nificant morbidity, most importantly, extremity amputa-
tion. According to recent estimates, there are 143,000
hospitalizations each year for PAD and 40,000 amputa-
tions, incurring an economic burden to the United States
health care system of $4 billion per year.1,2 The care of
patients with PAD encompasses a wide range of treatment
modalities, including preventive care, medical treatment,
exercise, and revascularization (open surgical and endovas-
cular). These modalities have proven effectiveness in im-
proving patient quality of life and preventing the progres-
sion of the disease to the point of amputation. During the
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doi:10.1016/j.jvs.2009.09.066past decade, endovascular therapy has become the treat-
ment modality of choice in the treatment of PAD.2
Within the United States, the treatment for PAD expe-
rienced by different racial/ethnic groups varies widely.
Overall population-based rates of amputation are higher for
black and Hispanic patients compared with white pa-
tients.3-7 The degree of these differences is surprising—the
rates of amputation in these minority groups are, depend-
ing on region, as much as four times higher than those in
nonminority groups.8 In this study, we examined the care
provided to patients who are hospitalized for PAD. Our
goal was to understand whether likelihood of obtaining a
particular treatment (amputation or revascularization, or
both) varies by race/ethnicity.
METHODS
This study was considered exempt from institutional
review by the Institutional Review Board of the Health
Sciences Campus of the University of Southern California.
Data source. TheNationwide Inpatient Sample (NIS)
from 1998 to 2006, comprising 69 million discharge
records, was used as source data for treatment patterns for
patients with PAD. Since 1988, the NIS has collected
information on approximately 20% of the hospital dis-
charges within the United States. To develop a sample that
most accurately represents hospitalizations within the
United States, hospitals are sampled according to specific
characteristics, including geographic region, hospital own-
ership, urban or rural location, and teaching status.9
The NIS reports data regarding admission type (eg,
urgent, emergent, elective) and source (eg, transfer, emer-
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patient was admitted through an emergency department,
or had an urgent or emergency admission type, were con-
sidered acute admissions. A hospitalization was considered
an acute admission for PAD if the patient was acutely
admitted and had a primary diagnosis of PAD (Interna-
tional Classification of Disease [ICD] code 440.2x).
Types of procedures were identified as open vascular
bypass, endovascular bypass, and major amputation based
on ICD procedure codes (Table I). A modified Charlson
score was computed based on diagnosis codes present in
the hospitalization abstract according to methods previ-
ously described.10 Because the patients in our sample all
had at least one comorbidity (vascular insufficiency), this
element of the comorbidity scoring was eliminated from
the computed Charlson score.
Analytic methods. Database manipulation was per-
formed using Visual Foxpro 9.0 software (Microsoft Inc,
Redmond, Wash). Statistical analyses were conducted with
SAS 9.1.3 software (SAS Institute Inc, Cary, NC). Multi-
variate logistic regression was used to analyze dichotomous
outcomes (eg, amputation performed  yes/no).
To account for insurance status within different age
groups, we parsed the data set into patients aged 65 vs
65 years. This allowed us to analyze the specific effect
of Medicare within these different age groups. Without
this manipulation, Medicare insurance status becomes
uninterpretable—patients aged65 years who hold Medi-
care insurance are generally either disabled or have end-
stage renal disease. These patients do dramatically worse
Table I. Description of International Classification of
Diseases, 9th Edition, (ICD-9) procedure codes used to
search the Nationwide Inpatient Sample database
Description ICD-9 code
Open vascular bypass procedures
Incision/exclusion/occlusion of aorta,
abdominal arteries, lower limb
arteries 38.14, 38.16, 38.18
Resection of lower limb artery,
replacement 38.48
Aortoiliac-femoral bypass 39.25
Other peripheral shunt/bypass 39.29
Other revision of vascular procedure 39.49
Repair of blood vessel with synthetic
patch graft 39.57
Endovascular procedures
Angioplasty or atherectomy of
noncoronary vessel 39.50
Insertion of noncoronary artery stent
or stents 39.90
Major amputation procedures
Disarticulation of ankle 84.13
Amputation of ankle through malleoli
of tibia and fibula 84.14
Other amputation below knee 84.15
Disarticulation of knee 84.16
Amputation above knee 84.17than other patients of similar age. By dividing the data set,we were able to examine Medicare insurance status within
that age group. We also sought to analyze temporal trends
in our multivariate analyses. In these analyses, we consid-
ered year of discharge to be a predictor variable of interest,
dummied into three categories: period 1 was 1998 to 2000,
period 2 was 2001 to 2003, and period 3 was 2004 to
2006.
Missing data. Approximately 25% of the NIS dis-
charge records are missing data elements for one or more
key patient factors. Race was the most common missing
variable because the states of Georgia, Illinois, Kentucky,
Minnesota, Nevada, Ohio, Oregon, and West Virginia do
not report race data on their discharge abstracts to the NIS.
To avoid a potential source of bias, we excluded discharge
data from these states. By excluding these records, how-
ever, we also altered the ability of the NIS sampling scheme
to be nationally representative. We therefore chose to ana-
lyze NIS data without regard to discharge weights, because
these weights would no longer be accurate after applying
the above-described exclusion. In doing so, we accept that
our analysis can no longer be considered truly representa-
tive of discharges in the United States.
RESULTS
Overall results. From within the NIS data set, we
identified 87,337 discharges for patients who were admit-
ted acutely with a diagnosis of PAD between 1998 and
2006. This number is a sampling of domestic discharges
and therefore does not represent an estimation of total
annual hospitalizations for PAD. Of the hospitalizations we
analyzed, 27.0% included an amputation, 19.3% an endo-
vascular procedure, and 30.2% an open vascular bypass.
Patient characteristics. The characteristics of the pa-
tients hospitalized in our study sample are summarized in
Table II. Patients who underwent amputation were slightly
older (mean, 73.8 years) than the overall cohort (mean,
71.9 years) or those who had an open bypass procedure
(mean, 69.8 years) or an endovascular procedure (mean,
70.1 years). Men predominated in all population groups
and subgroups.
Trends over time. The proportion of patients admit-
ted for acute PAD who underwent one of the three proce-
dures this study analyzed changed significantly during the
study period (Fig 1). Changes were the most dramatic in
the use of endovascular procedures, from 11.5% of admis-
sions in 1998 to35.3% in 2006. The use of open vascular
procedures and amputations both declined significantly.
The overall, unadjusted likelihood that an individual admit-
ted for acute PAD will undergo an amputation before
discharge is shown in Fig 2, categorized by race/ethnicity.
Between 1998 and 2006, the likelihood for all races de-
creased from 29.7% to 20.3%. Although decreases were
seen within all racial groups, a consistent difference is seen
between racial/ethnic groups, with black and Hispanic
patients more likely to undergo amputation than white
patients during all years of the study.
Multivariate analysis. We conducted six multivariate
analyses to understand the effect a broad range of factors on
are a
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procedure (Table III, A), (2) amputation (Table III, B),
and (3) endovascular procedure (Table III, C). These
analyses were stratified by age into patients 65 years
vs 65 years to provide better interpretation of insurance
status.
Temporal trends. The unadjusted analysis of tem-
Table II. Patient demographics from acute admissions for
Variable All admits
O
(n
Age, mean  SD, y 71.9  12.5 6
Female gender, % 47.3
Race/ethnicity, %
White 66.5
Black 19.6
Hispanic 6.4
Other/missing 7.5
Age group, %
65 ya 27.0
65 yb 73.0
Age 65 y, %
Private insurance 36.7
Medicare 35.2
Medicaid 18.7
Other/unknown 9.1
Age  y, %
Medicare 91.4
Private insurance 5.7
Other/unknown 2.8
Charlson score, %
0 27.4
1 14.0
2 26.1
3 18.7
aFigures in this row represent the proportion of patients in the column who
bFigures in this row represent the proportion of patients in the column who
Fig 1. Likelihood of amputation (white circles), endova
triangle) procedure is shown during an acute admissionporal trends shown in Fig 1 was confirmed in our multi-variate analysis. Open vascular bypass procedures and
amputations were less likely to be used in periods 2
and 3 than in period 1, and this finding was consistent
across age groups. Endovascular procedures showed the
most rapid change in likelihood of use (Table III, C).
The adjusted odds ratio (AOR) for undergoing an endo-
vascular procedure during an acute admission for PAD
pheral arterial disease
Procedure performed during admission
bypass
1,214)
Amputation
(n  18,980)
Endovascular
(n  13,539)
11.8 73.8  12.4 70.1  11.9
.9 48.6 47.4
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are ascularwas 3.23 (95% confidence interval [CI], 3.05-3.43)
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Age. Among patients aged 65 years, those aged 45
to 64 were more likely than patients aged 45 years to
undergo open or endovascular revascularization. There was
no difference, however, in likelihood of amputation.
Fig 2. Likelihood of a major amputation during an acute admis-
sion for peripheral arterial disease is shown by race/ethnicity.
Table III. A, Multivariate logistic regression for
likelihood of open vascular bypass during acute admission
for peripheral arterial disease
Variable
Patient age, AOR (95% CI)
65 y
(n  18,935)
65 y
(n  51,318)
Year of admission
Period 1: 1992-2000 1.00 1.00
Period 2: 2001-2003 0.87 (0.80-0.93) 0.88 (0.84-0.92)
Period 3: 2004-2006 0.68 (0.63-0.73) 0.73 (0.70-0.77)
Age, y
45-64 (vs 18-44) 1.37 (1.22-1.54) . . .
75 (vs 45-64) . . . 0.65 (0.62-0.67)
Female gender 0.86 (0.81-0.92) 0.92 (0.88-0.96)
Race/ethnicity
White 1.00 1.00
Black 0.88 (0.82-0.95) 0.69 (0.65-0.72)
Hispanic 0.78 (0.69-0.89) 0.75 (0.69-0.82)
Other/missing race 1.11 (0.99-1.25) 1.02 (0.94-1.09)
Primary payer (65 years)
Private 1.00 . . .
Medicare vs private 0.71 (0.66-0.76) . . .
Medicaid vs private 0.86 (0.79-0.94) . . .
Other/unknown vs
private 0.91 (0.82-1.02) . . .
Primary payer (65 years)
Medicare . . . 1.00
Private . . . 1.23 (1.14-1.33)
Other . . . 0.94 (0.84-1.06)
Charlson score
0 1.00 1.00
1 1.05 (0.94-1.18) 0.83 (0.79-0.88)
2 0.87 (0.80-0.93) 0.97 (0.92-1.01)
3 0.59 (0.54-0.65) 0.77 (0.73-0.81)
AOR, Adjusted odds ratio; CI, confidence interval.Among patients aged 65, those 75 were less likely toundergo open or endovascular revascularization and were
more likely to undergo amputation.
Gender. Women were less likely to undergo amputa-
tion or open vascular procedures than men and were more
likely to receive an endovascular procedure during an acute
hospitalization for PAD. These findings were true among
patients aged 65 or 65.
Race and ethnicity. Compared with white patients,
black and Hispanic patients of both age groups were less
likely to undergo an endovascular or open vascular proce-
dure during an admission for PAD. They were more likely
to undergo amputation. The magnitude of this effect for
the likelihood of amputation was larger among older pa-
tients and also greater among black vs white patients than
for Hispanic vs white patients.
Payer. Among younger patients, private insurance was
associated with a greater likelihood that a patient would
receive an open vascular or endovascular procedure and
would have a lower likelihood of amputation. The likeli-
hood of amputation was highest among those with Medi-
care (AOR, 2.11; 95% CI, 1.93-2.30). Among older pa-
tients, those with private insurance were more likely to have
an open or endovascular revascularization and less likely to
Table III. B, Multivariate logistic regression for
likelihood of amputation during acute admission for
peripheral arterial disease
Variable
Patient age, AOR (95% CI)
65 y
(n  18,935)
65 y
(n  51,318)
Year of admission
Period 1: 1992-2000 1.00 1.00
Period 2: 2001-2003 1.00 (0.92-1.09) 0.92 (0.88-0.96)
Period 3: 2004-2006 0.70 (0.64-0.76) 0.67 (0.64-0.71)
Age, y
45-64 vs 18-44 1.01 (0.89-1.15) . . .
75 vs 45-64 . . . 1.37 (1.31-1.42)
Female gender 0.89 (0.83-0.96) 0.95 (0.91-0.99)
Race/ethnicity
White 1.00 1.00
Black 1.60 (1.47-1.73) 2.49 (2.37-2.62)
Hispanic 1.29 (1.13-1.47) 1.43 (1.32-1.55)
Other/missing race 1.03 (0.90-1.19) 1.19 (1.10-1.28)
Primary payer (65 years)
Private 1.00 . . .
Medicare vs private 2.11 (1.93-2.30) . . .
Medicaid vs private 2.04 (1.84-2.26) . . .
Other/unknown vs
private 1.23 (1.07-1.43) . . .
Primary payer (65 years)
Medicare . . . 1.00
Private . . . 0.71 (0.65-0.78)
Other . . . 1.14 (1.02-1.28)
Charlson score
0 1.00 1.00
1 1.12 (0.97-1.29) 1.28 (1.21-1.36)
2 1.37 (1.25-1.50) 1.06 (1.01-1.11)
3 2.45 (2.24-2.69) 1.55 (1.47-1.64)
AOR, Adjusted odds ratio; CI, confidence interval.undergo amputation than patients covered with Medicare.
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bidity (higher modified Charlson score) had a lower likeli-
hood of undergoing an open vascular or endovascular
revascularization. A higher Charlson score was also associ-
ated with a higher risk of amputation. These findings were
consistent across age categories.
DISCUSSION
The main goal in the management of patients with
PAD is to maximize duration and quality of life, and
avoidance of lower extremity amputation is a benchmark of
success in achieving this goal. Patients who are hospitalized
with an acute manifestation of PAD are at a crossroads, and
their outcome surely depends on the ability of their treating
physicians to arrest the progression of their disease. In this
study, we used data from a nationally representative data set
to analyze the patterns of treatment provided to this pop-
ulation of patients—patients who are hospitalized acutely
for PAD.
Our study clearly documents a changing pattern of
treatment for patients who are hospitalized acutely for
PAD. During the 9-year period of our study, we saw a
distinct trend toward a lower likelihood of amputation and
Table III. C, Multivariate logistic regression likelihood
of an endovascular revascularization during an acute
admission for peripheral arterial disease
Variable
Patient age, AOR (95% CI)
65 y
(n  18,935)
65 y
(n  51,318)
Year of admission
Period 1: 1992-2000 1.00 1.00
Period 2: 2001-2003 1.47 (1.34-1.63) 1.55 (1.46-1.65)
Period 3: 2004-2006 2.87 (2.62-3.14) 3.23 (3.05-3.42)
Age, y
45-64 vs 18-44 1.17 (1.02-1.34) . . .
75 vs 45-64 . . . 0.70 (0.66-0.73)
Female gender 1.25 (1.16-1.35) 1.09 (1.04-1.14)
Race/ethnicity
White 1.00 1.00
Black 0.72 (0.66-0.79) 0.53 (0.49-0.57)
Hispanic 0.70 (0.60-0.81) 0.66 (0.59-0.73)
Other/missing race 0.81 (0.71-0.93) 0.77 (0.70-0.84)
Primary payer (65 y)
Private 1.00 . . .
Medicare vs private 0.59 (0.54-0.64) . . .
Medicaid vs private 0.52 (0.47-0.58) . . .
Other/unknown vs
private 0.69 (0.61-0.79) . . .
Primary payer (65 y)
Medicare 1.00 1.00
Private . . . 1.15 (1.04-1.26)
Other . . . 0.79 (0.68-0.93)
Charlson score
0 1.00 1.00
1 0.89 (0.78-1.02) 0.72 (0.67-0.77)
2 0.91 (0.84-0.99) 0.94 (0.89-0.99)
3 0.70 (0.63-0.77) 0.72 (0.67-0.77)
AOR, Adjusted odds ratio; CI, confidence interval.increased likelihood of obtaining an endovascular interven-tion, especially in patients aged 65 years. Although our
analyses cannot prove that endovascular technology is the
root cause of these improvements in amputation rates, the
circumstantial evidence for a causal link is strong.
Race/ethnicity remains an important correlate of out-
comes in patients with PAD. Our analysis demonstrates
that minorities are less likely than white patients to undergo
an open or endovascular revascularization and are more
likely to have a major amputation during an acute admis-
sion for PAD. The magnitude of our findings is somewhat
surprising. Of patients aged 65 years, black patients had
an AOR of 2.49 relative to white patients for amputation,
0.69 for open vascular bypass, and 0.53 for endovascular
revascularization. Findings were similar for Hispanic pa-
tients, albeit less dramatic. Patients 65 years also had
demonstrably different patterns of treatment across race/
ethnic lines. It is worth noting that the likelihood of ampu-
tation decreased for all groups during the course of our
study, suggesting that recent implementations of improv-
ing the care of patients with PAD have traversed across all
racial/ethnic boundaries. Despite the improvements in all
racial groups, the question still remains: Why the persistent
difference in the likelihood of amputations in Hispanic and
black patients?
A large body of population-based studies has consis-
tently documented higher rates of amputations in minority
patients, especially black patients. Initial studies performed
in the early 1990s used Medicare data to show that black
patients had higher rates of amputation and lower rates of
revascularization compared with white patients.5,6,11 More
recently, Eslami et al3 used the same NIS data set during a
4-year span (1998 to 2002) and analyzed multiple variables
thought to affect the disparity in the likelihood of amputa-
tions. They concluded that the higher amputation likeli-
hood in Hispanic and black patients was secondary to
advanced disease at presentation (ie, gangrene), lower so-
cioeconomic status, and lack of access to tertiary care
centers.
Although each study mentioned possible root causes,
few have offered an in-depth analysis. One interesting study
by Rucker-Whitaker et al12 proposed a unique explanation
for higher amputation rates among black patients. Using
data from a single academic institution, they concluded that
the differences in amputation rates in black patients might
be partially due to a higher likelihood of repeat amputa-
tions. The extent to which the findings from the Rucker-
Whitaker study can be generalized to a broader population
is unknown, but their approach raises the possibility that
minorities receive the same intensity of treatment but have
worse outcomes.
In 2007, we conducted a review of surgical outcomes in
patients undergoing lower extremity revascularization at
our large, urban public institution.13 In this setting, we
postulated a level playing field, with a population that was
homogenous to considerations of referral bias, poor com-
pliance, payer, and socioeconomic status. Our report
showed that black patients undergoing open surgical by-
pass for symptomatic PAD had statistically worse limb
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tients at 18 months of follow-up. Although this single-
institution study was preliminary, it did mandate consider-
ation of possible inherent differences (ie, upregulated
inflammatory markers, coagulation abnormalities, among
others) or responses to surgery among different popula-
tions of patients with PAD. The current study was not
designed to assess the degree to which these considerations
are important. A longitudinal evaluation of individual PAD
patients that assesses comorbidities and the burden of
disease at the time of diagnosis as well as surgical outcomes
is important.
Given the results of our study and the existing literature
to date, what do these findings mean? We have used the
term difference instead of disparity in the interest of adher-
ing to the definitions of the terms as described by Rathore
and Krumholz.14 They describe a “difference” as the ob-
served variation in health care use by race. A “disparity” is
when a racial difference in health care use reflects shortfalls
in appropriate care that cannot be explained by other
patient factors and are associated with adverse health con-
sequences. With this report, the noted differences could be
considered disparities if all other reasonable patient factors
were similar. These patient factors should include patient
preferences, access to care, and anatomic differences,
among others. Given the limitations of the data source used
in this study, we believe our investigation is not clearly able
to ascertain the presence of disparity. This distinction be-
tween difference and disparity, however, should not cloud
the importance of understanding the underlying reason for
the differences noted in our study and others.
Our study has several notable limitations. We were only
able to examine hospital-based care that occurred within
the context of an inpatient hospitalization. Admissions—
not procedures or patients—were the observations of inter-
est, making it impossible to analyze serial episodes of pa-
tient care. Also, our data source only captures inpatient
procedures, and we were not able to analyze outpatient
procedures performed for PAD and thus could not account
for secular trends that might have resulted in procedures
shifting from inpatient to outpatient environments. For
this reason, the rise in endovascular procedures in our
decade of interest may actually be underestimated.
Finally, we excluded data from nine states because they
do not report race data on their discharge abstracts to the
NIS. We have no reason to believe that this exclusion was a
source of bias, but we acknowledge that it does impair the
degree to which one considers our findings as truly nation-
ally representative.
CONCLUSIONS
We have shown that for a subset of patients with
PAD—those who are acutely hospitalized—that there are
significant differences in the types of treatment that are
provided across racial/ethnic groups. Black and Hispanic
patients undergo amputations more often and receive re-
vascularization less often, and these differences are dra-matic. To understand and potentially address the underly-
ing causes of these differences, population-based research
that encompasses a rich amount of clinical data is necessary.
Allowing these findings to continue unexamined is unac-
ceptable.
AUTHOR CONTRIBUTIONS
Conception and design: VR, FW, JL,
Analysis and interpretation: VR, JL, DE
Data collection: DE
Writing the article: VR, DE
Critical revision of the article: VR, FW, DE
Final approval of the article: VR, FW, DE
Statistical analysis: JL, DE
Obtained funding: Not applicable
Overall responsibility: VR, DE
REFERENCES
1. Hirsch AT, Hartman L, Town RJ, Virnig BA. National health care costs
of peripheral arterial disease in the Medicare population. Vasc Med
2008;13:209-15.
2. Rowe VL, Lee W, Weaver FA, Etzioni D. Patterns of treatment for
peripheral arterial disease in the United States: 1996-2005. J Vasc Surg
2009;49:910-7.
3. Eslami MH, Zayaruzny M, Fitzgerald GA. The adverse effects of race,
insurance status, and low income on the rate of amputation in patients
presenting with lower extremity ischemia. J Vasc Surg 2007;45:55-9.
4. Feinglass J, Kaushik S, Handel D, Kosifas A, Martin GJ, Pearce WH.
Peripheral bypass surgery and amputation: northern Illinois demo-
graphics, 1993 to 1997. Arch Surg 2000;135:75-80.
5. Guadagnoli E, Ayanian JZ, Gibbons G, McNeil BJ, LoGerfo FW. The
influence of race on the use of surgical procedures for treatment of
peripheral vascular disease of the lower extremities. Arch Surg 1995;
130:381-6.
6. McBean AM, Gornick M. Differences by race in the rates of procedures
performed in hospitals for Medicare beneficiaries. Health Care Financ
Rev 1994;15:77-90.
7. Tunis SR, Bass EB, Steinberg EP. The use of angioplasty, bypass
surgery, and amputation in the management of peripheral vascular
disease. N Engl J Med 1991;325:556-62.
8. Geography is destiny: differences in health care among Medicare bene-
ficiaries in the United States and California. Prepared for the California
HealthCare Foundation; November, 2008. Available at: http://www.
chcf.org/topics/view.cfm?itemID12388.
9. Agency for Healthcare Research and Quality. Introduction to the
HCUP Nationwide Inpatient Sample (NIS). 2006.
10. D’Hoore W, Bouckaert A, Tilquin C. Practical considerations on the
use of the Charlson comorbidity index with administrative data bases.
J Clin Epidemiol 1996;49:1429-33.
11. Gornick ME, Eggers PW, Reilly TW, Mentnech RM, Fitterman LK,
Kucken LE, et al. Effects of race and income on mortality and use of
services amongMedicare beneficiaries. N Engl J Med 1996;335:791-9.
12. Rucker-Whitaker C, Feinglass J, Pearce WH. Explaining racial variation
in lower extremity amputation: a 5-year retrospective claims data and
medical record review at an urban teaching hospital. Arch Surg 2003;
138:1347-51.
13. Rowe VL, Kumar SR, Glass H, Hood DB, Weaver FA. Race indepen-
dently impacts outcome of infrapopliteal bypass for symptomatic arterial
insufficiency. Vasc Endovascular Surg 2007;41:397-401.
14. Rathore SS, Krumholz HM. Differences, disparities, and biases: clarify-
ing racial variations in health care use. Ann Intern Med 2004;141:
635-8.Submitted Sep 17, 2009; accepted Sep 21, 2009.
